Laboratory diagnosis of paraneoplastic pemphigus

British Journal of Dermatology

Volumn 169, Issue 5, 2013, Pages 1016-1024

  Poot, A M ^a   Diercks, G F H ^a   Kramer, D ^a   Schepens, I ^b   Klunder, G ^a   Hashimoto, T ^c   Borradori, L ^b   Jonkman, M F ^a   Pas, H H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF BERN   (Switzerland)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ENVOPLAKIN; PEMPHIGUS ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BASEMENT MEMBRANE; BLADDER; BP180 ENZYME LINKED IMMUNOSORBENT ASSAY; BP230 ENZYME LINKED IMMUNOSORBENT ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENVOPLAKIN ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; LABORATORY DIAGNOSIS; MALE; OUTCOME ASSESSMENT; PARANEOPLASTIC PEMPHIGUS; PRIORITY JOURNAL; RADIOACTIVE IMMUNOPRECIPITATION; SENSITIVITY AND SPECIFICITY; SEROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CASE-CONTROL STUDIES; CLINICAL LABORATORY TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC TESTS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; RATS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER;

EID: 84886918763     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12479     Document Type: Article

References (38)

1. Anhalt GJ, Kim SC, Stanley JR, et al,. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729-35.
2. Nousari HC, Deterding R, Wojtczack H, et al,. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 1999; 340: 1406-10.
3. Takahashi M, Shimatsu Y, Kazama T, et al,. Paraneoplastic pemphigus associated with bronchiolitis obliterans. Chest 2000; 117: 603-7.
4. Leger S, Picard D, Ingen-Housz-Oro S, et al,. Prognostic factors of paraneoplastic pemphigus. Arch Dermatol 2012; 148: 1165-72.
5. Horn TD, Anhalt GJ,. Histologic features of paraneoplastic pemphigus. Arch Dermatol 1992; 128: 1091-5.
6. Anhalt GJ,. Paraneoplastic pemphigus. J Investig Dermatol Symp Proc 2004; 9: 29-33.
7. Mimouni D, Anhalt GJ, Lazarova Z, et al,. Paraneoplastic pemphigus in children and adolescents. Br J Dermatol 2002; 147: 725-32.
8. Zimmermann J, Bahmer F, Rose C, et al,. Clinical and immunopathological spectrum of paraneoplastic pemphigus. J Dtsch Dermatol Ges 2010; 8: 598-606.
9. Joly P, Richard C, Gilbert D, et al,. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 2000; 43: 619-26.
10. Nguyen VT, Ndoye A, Bassler KD, et al,. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol 2001; 137: 193-206.
11. Hayanga AJ, Lee TM, Pannucci CJ, et al,. Paraneoplastic pemphigus in a burn intensive care unit: case report and review of the literature. J Burn Care Res 2010; 31: 826-9.
12. Lyon CC, Carmichael AJ,. Toxic epidermal necrolysis and paraneoplastic pemphigus. Lancet 1998; 352: 149 (Letter).
13. Oursler JR, Labib RS, Ariss-Abdo L, et al,. Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest 1992; 89: 1775-82.
14. Hashimoto T, Amagai M, Watanabe K, et al,. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 1995; 104: 829-34.
15. Kim SC, Kwon YD, Lee IJ, et al,. cDNA cloning of the 210-kDa paraneoplastic pemphigus antigen reveals that envoplakin is a component of the antigen complex. J Invest Dermatol 1997; 109: 365-9.
16. Amagai M, Nishikawa T, Nousari HC, et al,. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 1998; 102: 775-82.
17. Borradori L, Trueb RM, Jaunin F, et al,. Autoantibodies from a patient with paraneoplastic pemphigus bind periplakin, a novel member of the plakin family. J Invest Dermatol 1998; 111: 338-40.
18. Hashimoto T, Amagai M, Ning W, et al,. Novel non-radioisotope immunoprecipitation studies indicate involvement of pemphigus vulgaris antigen in paraneoplastic pemphigus. J Dermatol Sci 1998; 17: 132-9.
19. Kiyokawa C, Ruhrberg C, Nie Z, et al,. Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex. J Invest Dermatol 1998; 111: 1236-8.
20. Mahoney MG, Aho S, Uitto J, Stanley JR,. The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol 1998; 111: 308-13.
21. Aho S, Mahoney MG, Uitto J,. Plectin serves as an autoantigen in paraneoplastic pemphigus. J Invest Dermatol 1999; 113: 422-3.
22. Hashimoto T,. Immunopathology of paraneoplastic pemphigus. Clin Dermatol 2001; 19: 675-82.
23. Sonnenberg A, Liem RK,. Plakins in development and disease. Exp Cell Res 2007; 313: 2189-203.
24. Schepens I, Jaunin F, Begre N, et al,. The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human. PLoS ONE 2010; 5: e12250.
25. Numata S, Teye K, Tsuruta D, et al,. Anti-alpha-2-macroglobulin-like-1 autoantibodies are detected frequently and may be pathogenic in paraneoplastic pemphigus. J Invest Dermatol 2013; 133: 1785-93.
26. Lambert J, Bracke S, van Roy F, et al,. Serum plakophilin-3 autoreactivity in paraneoplastic pemphigus. Br J Dermatol 2010; 163: 630-2.
27. Brandt O, Rafei D, Podstawa E, et al,. Differential IgG recognition of desmoglein 3 by paraneoplastic pemphigus and pemphigus vulgaris sera. J Invest Dermatol 2012; 132: 1738-41.
28. Helou J, Allbritton J, Anhalt GJ,. Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 1995; 32: 441-7.
29. Liu AY, Valenzuela R, Helm TN, et al,. Indirect immunofluorescence on rat bladder transitional epithelium: a test with high specificity for paraneoplastic pemphigus. J Am Acad Dermatol 1993; 28: 696-9.
30. Schafer S, Koch PJ, Franke WW,. Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of the desmoglein subfamily of desmosomal cadherins. Exp Cell Res 1994; 211: 391-9.
31. Probst C, Schlumberger W, Stocker W, et al,. Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus. Clin Chim Acta 2009; 410: 13-18.
32. Schmidt E, Zillikens D,. Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev 2010; 10: 84-9.
33. Czernik A, Camilleri M, Pittelkow MR, Grando SA,. Paraneoplastic autoimmune multiorgan syndrome: 20 years after. Int J Dermatol 2011; 50: 905-14.
34. Pas HH,. Immunoblot assay in differential diagnosis of autoimmune blistering skin diseases. Clin Dermatol 2001; 19: 622-30.
35. Kanitakis J,. Indirect immunofluorescence microscopy for the serological diagnosis of autoimmune blistering skin diseases: a review. Clin Dermatol 2001; 19: 614-21.
36. Galliano MF, Toulza E, Gallinaro H, et al,. A novel protease inhibitor of the alpha2-macroglobulin family expressed in the human epidermis. J Biol Chem 2006; 281: 5780-9.
37. Park GT, Quan G, Lee JB,. Sera from patients with toxic epidermal necrolysis contain autoantibodies to periplakin. Br J Dermatol 2006; 155: 337-43.
38. Cozzani E, Dal Bello MG, Mastrogiacomo A, et al,. Antidesmoplakin antibodies in pemphigus vulgaris. Br J Dermatol 2006; 154: 624-8.